OSE IMMUNOTHERAPEUTICS: ifrs:ExpenseFromSharebasedPaymentTransactionsWithEmployees
| Value | {"amount": 1911000.0} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | OSE IMMUNOTHERAPEUTICS |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:30:45.671935+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/4791803d-659a-4f58-bf07-ac3c4c9c3753
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500HIUWVGY6NZSM05:2025-12-31Retrieved: 2026-08-23T22:30:45.671935+02:00
Raw response sha256:
1c030fbf6937c66989de5e264e1a01e4…Cite as: FACTANKER, https://factanker.com/fact/4791803d-659a-4f58-bf07-ac3c4c9c3753
History
- no predecessors — first report